-
1.发明公开PYRIDOPYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USES AS ANTI-CANCER AND ANTI-DIABETE DRUGS 有权PYRIDOPYRAZOLOPYRIMIDINDERIVATE及其用来对付癌症和糖尿病
公开(公告)号：EP1853606A1
公开(公告)日：2007-11-14
申请号：EP06720539.3
申请日：2006-02-09
发明人： JUNG, David K., GlaxoSmithKline, Corp. Intellect. Property Dept. , ALBERTI, Michael J., GlaxoSmithKline, Corp. Intellectual Property Dept.
IPC分类号： C07D471/14 , A61K31/495 , A61P35/00 , A61P3/10
CPC分类号： C07D471/14
摘要： The present invention relates to pyridopyrazolopyrimidine derivatives that are useful pharmacological agents through the inhibition or antagonism of protein kinases, and to processes for the preparation and use of the same. In particular, the present invention relates to compounds that demonstrate protein tyrosine kinase and/or protein serine/threonine kinase inhibition.
-
2.发明授权PYRIDOPYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USES AS ANTI-CANCER AND ANTI-DIABETE DRUGS 有权PYRIDOPYRAZOLOPYRIMIDINDERIVATE及其用来对付癌症和糖尿病
公开(公告)号：EP1853606B1
公开(公告)日：2008-11-19
申请号：EP06720539.3
申请日：2006-02-09
发明人： JUNG, David K., GlaxoSmithKline, Corp. Intellect. Property Dept. , ALBERTI, Michael J., GlaxoSmithKline, Corp. Intellectual Property Dept.
IPC分类号： C07D471/14 , A61K31/495 , A61P35/00 , A61P3/10
CPC分类号： C07D471/14
摘要： The present invention relates to pyridopyrazolopyrimidine derivatives that are useful pharmacological agents through the inhibition or antagonism of protein kinases, and to processes for the preparation and use of the same. In particular, the present invention relates to compounds that demonstrate protein tyrosine kinase and/or protein serine/threonine kinase inhibition.
-
搜索结果
2 条记录 (耗时 0.01 秒)
